Topics were organized in five themes: the availability of biosimilars, pricing policies, reimbursement policies, demand-side policies (broken down by the 4Es–Education, Engineering, Economics and Enforcement [18]), and recommendations to enhance uptake of biosimilars.
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}